[Form 3] Health Catalyst, Inc. Initial Statement of Beneficial Ownership
Albert Benjamin filed an initial Form 3 reporting his beneficial ownership in Health Catalyst, Inc. (HCAT). He directly holds 92,870 common shares and 18,000 restricted stock units (RSUs) granted under the 2019 Plan that vest beginning March 1, 2026. He also reports indirect holdings of 148,198 shares via the "Benjamin Albert Declaration of Trust" and 28,697 shares via the "Albert Family Trust." The filing is signed by an attorney-in-fact on 09/26/2025.
Albert Benjamin ha presentato un modulo iniziale Form 3 per riferire la sua proprietà beneficiaria su Health Catalyst, Inc. (HCAT). Possiede direttamente 92,870 azioni ordinarie e 18,000 unità di azioni vincolate (RSU) conferite ai sensi del Piano 2019 che vestono a partire dal 1 marzo 2026. Riporta inoltre partecipazioni indirette di 148,198 azioni tramite l''Albert Benjamin Declaration of Trust e 28,697 azioni tramite l''Albert Family Trust. La presentazione è firmata da un procuratore in fact il 26/09/2025.
Albert Benjamin presentó un Formulario 3 inicial reportando su propiedad beneficiaria en Health Catalyst, Inc. (HCAT). Posee directamente 92,870 acciones ordinarias y 18,000 unidades de acciones restringidas (RSU) otorgadas bajo el Plan de 2019 que vencen a partir del 1 de marzo de 2026. También informa participaciones indirectas de 148,198 acciones a través del 'Benjamin Albert Declaration of Trust' y 28,697 acciones a través del 'Albert Family Trust'. El documento está firmado por un apoderado el 26/09/2025.
앨버트 벤자민은 Health Catalyst, Inc. (HCAT)에 대한 그의 유익 소유를 보고하는 초기 Form 3를 제출했습니다. 그는 직접 92,870주의 보통주와 2019년 플랜에 따라 2026년 3월 1일부터 가속 vesting되는 18,000주의 RSU를 보유합니다. 또한 'Benjamin Albert Declaration of Trust'를 통해 148,198주의 간접 보유와 'Albert Family Trust'를 통해 28,697주의 보유를 보고합니다. 이 서류는 2025년 9월 26일 대리인이 서명했습니다.
Albert Benjamin a déposé un formulaire initial Form 3 signalant sa propriété bénéficiaire sur Health Catalyst, Inc. (HCAT). Il détient directement 92 870 actions ordinaires et 18 000 unités d’actions restreintes (RSU) accordées dans le cadre du Plan de 2019, qui vestent à compter du 1er mars 2026. Il déclare également des participations indirectes de 148 198 actions via le « Benjamin Albert Declaration of Trust » et 28 697 actions via le « Albert Family Trust ». Le dépôt est signé par un mandataire le 26/09/2025.
Albert Benjamin hat einen initialen Form 3 eingereicht, um seinen wirtschaftlichen Eigentumsanteil an Health Catalyst, Inc. (HCAT) zu melden. Er besitzt direkt 92.870 Stammaktien und 18.000 Restricted Stock Units (RSU), die gemäß dem Plan von 2019 gewährt wurden und ab dem 1. März 2026 vesten. Er meldet außerdem indirekte Beteiligungen von 148.198 Aktien über die Benjamin Albert Declaration of Trust und 28.697 Aktien über den Albert Family Trust. Die Einreichung wurde am 26.09.2025 von einem Bevollmächtigten unterzeichnet.
قدّم ألبرت بنيامين استمارة Form 3 الأولية للإبلاغ عن ملكيته المستفيدة في Health Catalyst, Inc. (HCAT). يمتلك مباشرة 92,870 سهماً عَادياً و 18,000 وحدة أسهم مقيدة (RSUs) ممنوحة بموجب خطة 2019 التي تتحقق vesting اعتباراً من 1 مارس 2026. كما يذكر امتلاكاً غير مباشر قدره 148,198 سهماً عبر 'Benjamin Albert Declaration of Trust' و 28,697 سهماً عبر 'Albert Family Trust'. التوقيع على الملف من قبل وكيل رسمي في 26/09/2025.
阿尔伯特·本杰明已提交初始表格3,报告他在 Health Catalyst, Inc.(HCAT)上的受益所有权。他直接持有 92,870 股普通股和 18,000 份受限股票单位(RSU),这些 RSU 根据 2019 年计划授予,将自 2026 年 3 月 1 日起归属。他还通过“Benjamin Albert Declaration of Trust”间接持有 148,198 股,以及通过“Albert Family Trust”持有 28,697 股。该备案由代理律师在 2025-09-26 签署。
- Clear disclosure of direct and indirect holdings including RSUs and trust holdings
- RSU vesting schedule is specified (25% on March 1, 2026; remaining in 12 quarterly installments), providing transparency on future share issuance timing
- None.
Insights
TL;DR: Reporting discloses executive ownership with vested and unvested equity, aligning management compensation with shareholder outcomes.
The Form 3 shows a mix of direct shares and trust-held indirect shares plus RSUs subject to vesting under the 2019 Plan. The RSU vesting schedule (25% on March 1, 2026, then quarterly) indicates future share issuance timing that may modestly increase diluted share count. Holdings by family trusts are disclosed, which is common for estate planning and does not signal a change in control.
TL;DR: Routine initial ownership disclosure consistent with Section 16 reporting requirements; no governance red flags apparent.
The filing identifies the reporting person as President and COO and discloses trustee relationships for two trusts. The declaration that the reporting person serves as trustee and beneficiaries include immediate family is clearly stated. Signature by attorney-in-fact is noted. There are no amendments or unusual arrangements disclosed.
Albert Benjamin ha presentato un modulo iniziale Form 3 per riferire la sua proprietà beneficiaria su Health Catalyst, Inc. (HCAT). Possiede direttamente 92,870 azioni ordinarie e 18,000 unità di azioni vincolate (RSU) conferite ai sensi del Piano 2019 che vestono a partire dal 1 marzo 2026. Riporta inoltre partecipazioni indirette di 148,198 azioni tramite l''Albert Benjamin Declaration of Trust e 28,697 azioni tramite l''Albert Family Trust. La presentazione è firmata da un procuratore in fact il 26/09/2025.
Albert Benjamin presentó un Formulario 3 inicial reportando su propiedad beneficiaria en Health Catalyst, Inc. (HCAT). Posee directamente 92,870 acciones ordinarias y 18,000 unidades de acciones restringidas (RSU) otorgadas bajo el Plan de 2019 que vencen a partir del 1 de marzo de 2026. También informa participaciones indirectas de 148,198 acciones a través del 'Benjamin Albert Declaration of Trust' y 28,697 acciones a través del 'Albert Family Trust'. El documento está firmado por un apoderado el 26/09/2025.
앨버트 벤자민은 Health Catalyst, Inc. (HCAT)에 대한 그의 유익 소유를 보고하는 초기 Form 3를 제출했습니다. 그는 직접 92,870주의 보통주와 2019년 플랜에 따라 2026년 3월 1일부터 가속 vesting되는 18,000주의 RSU를 보유합니다. 또한 'Benjamin Albert Declaration of Trust'를 통해 148,198주의 간접 보유와 'Albert Family Trust'를 통해 28,697주의 보유를 보고합니다. 이 서류는 2025년 9월 26일 대리인이 서명했습니다.
Albert Benjamin a déposé un formulaire initial Form 3 signalant sa propriété bénéficiaire sur Health Catalyst, Inc. (HCAT). Il détient directement 92 870 actions ordinaires et 18 000 unités d’actions restreintes (RSU) accordées dans le cadre du Plan de 2019, qui vestent à compter du 1er mars 2026. Il déclare également des participations indirectes de 148 198 actions via le « Benjamin Albert Declaration of Trust » et 28 697 actions via le « Albert Family Trust ». Le dépôt est signé par un mandataire le 26/09/2025.
Albert Benjamin hat einen initialen Form 3 eingereicht, um seinen wirtschaftlichen Eigentumsanteil an Health Catalyst, Inc. (HCAT) zu melden. Er besitzt direkt 92.870 Stammaktien und 18.000 Restricted Stock Units (RSU), die gemäß dem Plan von 2019 gewährt wurden und ab dem 1. März 2026 vesten. Er meldet außerdem indirekte Beteiligungen von 148.198 Aktien über die Benjamin Albert Declaration of Trust und 28.697 Aktien über den Albert Family Trust. Die Einreichung wurde am 26.09.2025 von einem Bevollmächtigten unterzeichnet.